Circle generated about $1.4 billion in revenue in the first half of 2026, allocating 59% to USDC distribution partners and transaction costs, and 34% to licensing, banking, compliance, and product development. USDC settled over $36 trillion in onchain transactions and accounted for 77% of global stablecoin transaction volume by June, up from 60% a year earlier. More than 150 partners benefit economically from USDC's growth, with customers able to redeem USDC for free through various channels. This strong performance highlights USDC's dominant role in the stablecoin market and its extensive partner ecosystem.
Circle's first-half revenue allocation and USDC transaction volume provide context for readers. For those tracking cryptocurrency markets, 10 of 50 major cryptocurrencies on Pluang rose while 39 fell. EOS gained 8.13% to Rp12.649, CRV dropped 3.96% to Rp6.181 with 79% sell orders, and SAND declined 3.89% to Rp974 with 59% buy orders as of Oct 17, 2026 04:51 WIB.
Changan Automobile announced new partnerships covering seven European markets and launched its "with U" service program at Mondial de l’Auto 2026. This marks a shift from market entry to building a local ecosystem including manufacturing, sales, serv...
At the 2026 Mondial de l’Auto, Changan Automobile signed letters of intent with eight companies across seven European markets and launched its "with U" service program. This marks a strategic move to build a strong local ecosystem combining manufactu...
Northland Power Inc. announced it will release its third quarter 2026 financial results after market close on November 12, 2026. The company will host an earnings call and webcast on November 13 at 9:00 a.m. ET, providing investors an opportunity to ...
Several daily leveraged ETFs tied to tech and crypto-related stocks dropped sharply, with declines over 20%. Notable falls include GraniteShares 2x Long NBIS Daily ETF down 24.5% and Leverage Shares 2x Long CRWV Daily ETF down 23.9%. These ETFs aim t...
Recent biotech IPOs Iambic Therapeutics and City Therapeutics saw significant price jumps, rising 25.9% and 22.2% respectively after their market debuts, raising substantial capital. Inverse leveraged ETFs SMCZ and SMST also gained sharply as their u...
